Patents by Inventor Mark Andrew GALLOP

Mark Andrew GALLOP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclic compounds as androgen receptor modulators
    Patent number: 12012398
    Abstract: Provided herein are compounds that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease.
    Type: Grant
    Filed: July 11, 2022
    Date of Patent: June 18, 2024
    Assignee: NIDO BIOSCIENCES, INC.
    Inventors: Bakary-Barry Toure, Mark Andrew Gallop
  • INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
    Publication number: 20230348439
    Abstract: Provided herein are indole compounds that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy’s disease
    Type: Application
    Filed: February 22, 2023
    Publication date: November 2, 2023
    Inventors: Bakary-Barry TOURE, Mark Andrew GALLOP, Paul Andrew BARSANTI
  • Indole compounds as androgen receptor modulators
    Patent number: 11667624
    Abstract: Provided herein are indole compounds that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: June 6, 2023
    Assignee: NIDO BIOSCIENCES, INC.
    Inventors: Bakary-Barry Toure, Mark Andrew Gallop, Paul Andrew Barsanti
  • INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
    Publication number: 20230049406
    Abstract: Provided herein are indole compounds that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease
    Type: Application
    Filed: July 20, 2021
    Publication date: February 16, 2023
    Inventors: Bakary-Barry TOURE, Mark Andrew GALLOP, Paul Andrew BARSANTI
  • BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
    Publication number: 20230039586
    Abstract: Provided herein are compounds that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease
    Type: Application
    Filed: July 11, 2022
    Publication date: February 9, 2023
    Inventors: Bakary-Barry TOURE, Mark Andrew GALLOP
  • BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
    Publication number: 20220306609
    Abstract: Provided herein are indole compounds that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease
    Type: Application
    Filed: March 23, 2022
    Publication date: September 29, 2022
    Inventors: Bakary-Barry TOURE, Mark Andrew GALLOP, Hanmo ZHANG